In recent years, melanoma treatment has included conventional chemotherapy and radiation therapy and therapies targeting B-raf proto-oncogene, serine/threonine kinase (BRAF), and MAP kinase-ERK kinase. This evidence concerns the gene BRAF and melanoma.